A detailed history of Core Cap Advisors, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 600 shares of TMDX stock, worth $48,558. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 420 42.86%
Holding current value
$48,558
Previous $63,000 49.21%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$135.68 - $176.11 $24,422 - $31,699
180 Added 42.86%
600 $94,000
Q2 2024

Aug 08, 2024

BUY
$72.62 - $150.62 $30,500 - $63,260
420 New
420 $63,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.58B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.